Asystole-patients (n = 37) | VF-patients (n = 77) | P-value | |
---|---|---|---|
Age, y | 75 (66–86) | 63 (54–75) | < 0.001 |
Male sex | 26 (70) | 69 (90) | 0.015 |
Death at 30 days | 37 (100) | 33 (43) | < 0.001 |
Died on scene | 26 (70) | 9 (12) | |
Died in hospital | 11 (30) | 24 (31) | |
Cardiac arrest conditions | |||
Witnessed cardiac arrest | 26 (70) | 61 (80) | 0.24 |
Bystander-initiated CPR | 26 (70) | 67 (87) | 0.040 |
Duration of resuscitation, min | 28.5 (20–35) | 15 (6–43) | 0.082 |
Previous history | |||
Angina pectoris | 9 (32) | 8 (12) | 0.037 |
Myocardial infarction | 11 (32) | 22 (30) | 0.82 |
Previous PCI | 4 (12) | 8 (11) | 1.00 |
Previous CABG | 5 (15) | 7 (10) | 0.51 |
Heart failure | 11 (33) | 17 (23) | 0.34 |
Hypertension | 21 (64) | 32 (46) | 0.097 |
Diabetes mellitus | 7 (21) | 10 (14) | 0.40 |
Hypercholesterolemia | 12 (36) | 32 (44) | 0.53 |
Smoking | 0.56 | ||
Current smoker | 10 (39) | 17 (29) | |
Ex-smoker | 10 (39) | 30 (51) | |
Baseline blood samples | |||
Creatinine (μmol/L) | 101 (92–130) | 102 (87–121) | 0.42 |
Total cholesterol (mmol/L) | 4.1 (3.5–5.0) | 4.3 (3.7–5.4) | 0.16 |
CRP (mg/L) | 12.0 (2.0–50.0) | 1.9 (1.1–4.1) | < 0.001 |
Glucose (mmol/L) | 10.7 (3.7–15.7) | 13.7 (9.6–17.2) | 0.034 |
Copeptin (pmol/L)a | 402 (244–939) | 453 (210–765) | 0.82 |
hs-cTnT (ng/L)b | 67 (28–226) | 73 (26–231) | 0.77 |
NT-proBNP (pmol/L)c | 250 (42–1305) | 51 (18–111) | < 0.001 |